Fig. 1: Survival outcomes.
Overall survival and leukemia-free survival of all patients included in the study (a). Overall survival (b) and leukemia-free survival (c) of patients according to Allo-HCT Refined ELN2022 risk classification.
Fig. 1: Survival outcomes. | Blood Cancer Journal
